Description: Novozymes is the biotech-based world leader in enzymes and microorganisms. With more than 100 types of enzymes and microorganisms and not less than 700 different products Novozymes has the largest product portfolio in the world. In more than 40 different industries and 130 countries, our biological solutions improve industrial performance and quality while at the same time saving on water, energy, raw materials and waste. Novozymes is quoted on the Copenhagen Stock Exchange.
Home Page: www.novozymes.com
Krogshoejvej 36
Bagsvaerd,
2880
Denmark
Phone:
45 44 46 00 00
Officers
| Name | Title |
|---|---|
| Ms. Ester Baiget | Pres & CEO |
| Mr. Lars Green M.Sc., MSc | Exec. VP & CFO |
| Ms. Graziela Chaluppe dos Santos Malucelli | COO and Exec. VP of Operations, Supply & Quality |
| Mr. Tobias Cornelius Bjorklund | Head of Investor Relations |
| Mr. Tue Micheelsen | VP of Global Sales & Marketing |
| Mr. Morten Enggaard Rasmussen | Exec. VP of People, Sustainability & Brand |
| Mr. Pedro Luiz Fernandes | Head of Corp. Affairs & Sustainability - Novozymes Latin America |
| Mr. Anders Lund | Exec. VP of Consumer Biosolutions |
| Mr. Sebastian Søderberg | VP and Head of New Bus. Devel. - Incubations & Acquisitions |
| Ms. Tina Sejersgaard Fanoe | Exec. VP of Agriculture & Industrial Biosolutions |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 29.6736 |
|---|---|
| Trailing PE: | 29.4154 |
| Price-to-Book MRQ: | 6.1921 |
| Price-to-Sales TTM: | 0.8229 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 6741 |